Actual concepts in the therapy of reflux disease;Aktuelle konzepte in der therapie der refluxerkrankung

Wiener Medizinische Wochenschrift

Volumn 151, Issue 11-12, 2001, Pages 266-269

  Kirchgatterer, A ^a   Aschl, G ^a   Hinterreiter, M ^a   Stadler, B ^a   Knoflach, P ^a  

^a Krankenhaus Barmherzigen Schwestern   (Germany)

Author keywords

Esophagitis; Fundoplication; Proton pump inhibitor; Reflux disease

Indexed keywords

PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; DRUG EFFICACY; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HEALING; REVIEW;

ANTI-ULCER AGENTS; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; PROTON PUMPS; TREATMENT OUTCOME;

EID: 0034928611     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: Randomised clinical trial
2. Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease
3. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
4. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: A European multicentre study
5. Laparoscopic Nissen fundoplication: Preliminary report
6. An evidence-based appraisal of reflux disease management - The Genval Workshop Report
7. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: A controlled, double-blind study
8. A study of 362 consecutive laparoscopic Nissen fundoplications
9. Current status and trends in laparoscopic antireflux surgery: Results of a consensus meeting
10. Healing and relapse of severe peptic esophagitis after treatment with omeprazole
11. The rationale for continuous maintenance treatment of reflux esophagitis
12. Ambulatory 24-hour esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility
13. Gastroesophageal reflux disease and its complications
14. Quality of life and surgical outcome after laparoscopic Nissen and Toupet fundoplication: One-year follow-up
15. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
16. Does Helicobacter pylori affect the management of gastroesophageal reflux disease?
17. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
18. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
19. Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: Results of a prospective, randomized clinical trial
20. Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classsification
21. Symptomatic gastroesophageal reflux: Incidence and precipitating factors
22. Savary-Miller's new endoscopic grading of reflux-oesophagitis: A simple, reproductible, logical, complete and useful classification
23. The natural history, prevalence and incidence of reflux oesophagitis
24. The prevalence of gastro-oesophageal reflux disease
25. Acid-reflux disorders
26. Clinical epidemiology and natural history of gastroesophageal reflux disease
27. Gastric emptying: A contributary factor in gastro-esophageal reflux activity?
28. Oesophageal disorders and gastro-oesophageal reflux disease
29. A learning curve for laparoscopic fundoplication: Definable, avoidable, or a waste of time?
30. Epidemiology of reflux disease and reflux esophagitis